lidocaine and Temporomandibular Disorders

lidocaine has been researched along with Temporomandibular Disorders in 28 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Research

Studies (28)

Authors

Clinical Trials (1)

Trial Overview

Trial Outcomes

Bradykinesia Measure Before and After Real and Sham tDCS.

Bradykinesia refers to the slowness in executing a movement. Bradykinesia was assessed by measuring the time in seconds it takes to do the following sequence, 10 times: 1) hand closing and opening while squeezing a ball 2) elbow flexion 3) hand closing and opening, and 4) elbow extension. Subjects were allowed to practice these hand and arm movements until performance appeared not to get faster, and then were abstained from further practice to minimize learning effects. The time it takes subjects to execute the entire sequence 10 times with either the left or right arm/hand was measured. Means are reported for each group. (NCT00082342)
Timeframe: baseline, 1 day post, 1 month post, 3 months post tDCS

Gait Speed Before and After Real and Sham tDCS.

Gait speed was measured by the time it took the subject to walk 10m. Subjects were instructed to walk at a fast pace without taking the risk of falling, wearing the same shoes and using assistive devices consistently if needed. Gait speed was measured at baseline and post-tDCS. (NCT00082342)
Timeframe: baseline, 1 day post, 1 month post, 3 months post-tDCS

UPDRS Motor Scores Before and After Real tDCS Course and After Sham tDCS Course.

The Motor Unified Parkinson's Disease Rating Scale (UPDRS) includes only the motor assessment of the UPDRS (Part III) and examines speech, facial expression, tremor at rest, action tremor, rigidity, finger taps, hand movements, hand pronation and supination, leg agility, arising from chair, posture, gait, postural stability and body bradykinesia. The scores range from 0 (no motor impairment) to 108 (severe motor impairment). The Motor UPDRS was administred at baseline and at 1 day post, 1 month post, and 3 months post tDCS or sham. Subjects were assessed on medication and off medication. (NCT00082342)
Timeframe: baseline, 1 day post, 1 month post, and 3 months post real and sham tDCS

UPDRS Total Scores Before and After Real tDCS Course and After Sham tDCS Course.

The Total Unified Parkinson's Disease Rating Scale (UPDRS) is an overall clinical rating scale that quantifies the signs and symptoms of Parkinson's disease. The total UPDRS score was obtained from subject examination, subject interviews and questionnaires. The UPDRS encompasses measurement of mentation, behavior, mood, activities of daily living and motor skills. The total UPDRS scores ranges from 0 (not affected) to 176 (most severely affected). The UPDRS was administred at baseline and at 1 day post, 1 month post, and 3 months post tDCS or sham, while on medication and off medication. (NCT00082342)
Timeframe: baseline, 1 day post, 1 month post, 3 months post-tDCS

Reviews

1 review available for lidocaine and Temporomandibular Disorders

Trials

7 trials available for lidocaine and Temporomandibular Disorders

Other Studies

20 other studies available for lidocaine and Temporomandibular Disorders